About: Dimerix Limited, a biopharmaceutical company, develops and commercializes pharmaceutical products for unmet medical needs in Australia. It develops DMX-200 for the treatment of focal segmental glomerulosclerosis disease; as well as DMX-652 for the treatment of acute kidney injury. The company is headquartered in Fitzroy, Australia.
Sector: Healthcare
Industry: Biotechnology
Latest price: A$0.21 (-2.33%)
DXB ASX Dimerix Ltd
Loading watchlist status…
Dimerix Ltd share price
DXB price activity
Last Price
$0.210
Change (24hr)
-0.01 AUD (2.33%)
Volume
333.87K
Volume (4w avg)
-
Open
$0.22
Day Range
$0.21 - $0.22
Previous Close
$0.22
Last Trade
30 Oct, 5:10 am GMT+0
Delayed
30 Oct, 5:10 am GMT+0
DXB price performance
+5.00%
5D
-8.70%
1M
-61.82%
YTD
-57.14%
1Y
Delayed
30 Oct, 5:10 am GMT+0
DXB Market Signals